Close Menu

NEW YORK – Spatial genomics startup Vizgen said on Thursday that it has raised $37 million in an oversubscribed Series B financing.

Novalis LifeSciences and Northpond Ventures led the round, joined by new investors Tao Capital Partners, Pura Vida Investments, and an unspecified US endowment fund as well as existing investors Arch Venture Partners and David Walt. Walt, a professor at Harvard Medical School, is a Vizgen cofounder and board member.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.